A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

Clinical trial NCT02003534 · COMPLETED

Trial details

NCT number: NCT02003534
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma, Open-Angle Ocular Hypertension

Start date: 2010-07-01
Primary completion: 2013-02-01
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.